| GeneLibs

题目:: High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
作者:: Johannesdottir(G),Gudmundsson(J),Bergthorsson(J T),Arason(A),Agnarsson(B A),Eiriksdottir(G),Johannsson(O T),Borg(A),Ingvarsson(S),Easton(D F),Egilsson(V),Barkardottir(R B)
状态:: 发布时间1996-09-10 , 更新时间 2006-11-15
期刊:: Cancer Res
摘要:: Studies on Icelandic breast cancer families have shown that most of them segregate a 999del5 BRCA2 mutation. Here, we report the frequency of the 999del5 BRCA2 mutation in an Icelandic control population and four different groups of cancer patients diagnosed with (a) breast cancer; (b) ovarian cancer; (c) prostate cancer (patients younger than 65 years); and (d) other cancer types. The proportions of individuals carrying the mutation were 0.4% in the control population and in the patient groups 8.5%, 7.9%, 2.7%, and 1.0%, respectively. Our results indicate that BRCA2 confers a very high risk of breast cancer and is responsible for a substantial fraction of breast and ovarian cancer in Iceland, but only a small proportion of other cancers.
语言:: eng
DOI:

文献库文献相关信息